Robert Weinberg | |
---|---|
Born | Robert Allan Weinberg November 11, 1942 Pittsburgh, Pennsylvania, U.S. |
Nationality | American |
Alma mater | Massachusetts Institute of Technology (BS, PhD) |
Known for |
|
Awards |
|
Scientific career | |
Fields | Molecular biology Oncology |
Institutions | |
Doctoral students | |
Website | weinberglab |
Robert Allan Weinberg (born November 11, 1942) is an American biologist, Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology (MIT), director of the Ludwig Center of the MIT, and American Cancer Society Research Professor. His research is in the area of oncogenes and the genetic basis of human cancer. [2] [3] [4]
Robert Weinberg is also affiliated with the Broad Institute and is a founding member of the Whitehead Institute for Biomedical Research. [5] Weinberg and Eric Lander, a colleague at M.I.T., are co-founders of Verastem, a biopharmaceutical company focused on discovering and developing drugs to treat cancer by targeting cancer stem cells. [6]
Weinberg earned SB in Biology from Massachusetts Institute of Technology in 1964 and PhD in biology from the same institute in 1969. He was an instructor in biology at Stillman College in Tuscaloosa, Alabama (1965–1966), and a postdoc in Ernest Winocour's lab at the Weizmann Institute of Science (1969–1970) and in Renato Dulbecco's lab at the Salk Institute for Biological Studies (1970–1972). He joined MIT in 1972. [7]
He is best known for his discoveries of the first human oncogene Ras and the first tumor suppressor gene Rb [8] p. 371-381, which is partially documented in Natalie Angier′s book, Natural Obsessions, about her year spent in Weinberg's lab.
In the late 20th century, advances in genetics led to the discovery of over one hundred cancer cell types. Cancer cells were noted for their bewildering diversity. It was hard to identify the principles that cancers had in common.
He and Douglas Hanahan wrote the seminal paper "The Hallmarks of Cancer", published in January 2000, [9] that gave the six requirements for one renegade cell to cause a deadly cancer: [8] In 2011, they published an updated review article entitled "Hallmarks of cancer: the next generation". [10]
Capability | Simple analogy |
---|---|
Self-sufficiency in growth signals | "accelerator pedal stuck on" |
Insensitivity to anti-growth signals | "brakes don't work" |
Evading apoptosis | won't die when the body normally would kill the defective cell |
Limitless replicative potential | infinite generations of descendants |
Sustained angiogenesis | asking the body to give it a blood supply |
Tissue invasion and metastasis | migrating and spreading to other organs and tissues |
Weinberg is well known for both his cancer research [11] and for his mentorship of many eminent scientists, including Tyler Jacks, William C. Hahn, Clifford Tabin, Sendurai Mani and Cornelia Bargmann. He is currently studying cancer cell metastasis. [12]
He is also the author of the textbook The Biology of Cancer [1] published by Garland Science, as well as two important accounts intended for a wider audience: One Renegade Cell: How Cancer Begins (1999) (Science Masters Series); and Racing to the Beginning of the Road: The Search for the Origin of Cancer (1996).
As of 2021 [update] , Weinberg has an h-index of 209 according to Google Scholar. [13]
In 1985, Weinberg received the Golden Plate Award of the American Academy of Achievement. [14] Weinberg won the National Medal of Science and the Keio Medical Science Prize in 1997. In 1999, he received the Albert Einstein World Award of Science in recognition of his valuable and pioneering contributions in the field of Biomedical Sciences and for his productive trajectory related to the genetic and molecular basis of neoplastic disease. [15] He was elected to the American Philosophical Society in 2000. [16] He obtained the Wolf Prize in Medicine in 2004 (shared with Roger Y. Tsien), and he is a member of the U.S. National Academy of Sciences. In 2007 he received an honorary doctorate degree in commemoration of Linnaeus from Uppsala University. He is a member of the Royal Swedish Academy of Sciences since 1992. [17] In 2009 he was presented the Hope Funds Award in Basic Research. [18] In 2013 he was awarded the $3 million Breakthrough Prize in Life Sciences for his work [19] and in 2021 he received the Japan Prize. [20]
To this day Weinberg has had five research papers retracted where he is listed as a co-author. The retractions include one paper in Cell, one in Cancer Cell, two in Genes & Development and one in Cancer Research. [21] [22] [23] [24] This is out of over 450 publications since 1963.
The reasons given for the retraction of one paper (DOI: 10.1016/j.cell.2009.03.04) include: "Falsification/Fabrication of Data" and "Manipulation of Results".
An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated, or expressed at high levels.
Susan Lee Lindquist, ForMemRS was an American professor of biology at MIT specializing in molecular biology, particularly the protein folding problem within a family of molecules known as heat-shock proteins, and prions. Lindquist was a member and former director of the Whitehead Institute and was awarded the National Medal of Science in 2010.
Howard Robert Horvitz ForMemRS NAS AAA&S APS NAM is an American biologist whose research on the nematode worm Caenorhabditis elegans was awarded the 2002 Nobel Prize in Physiology or Medicine, together with Sydney Brenner and John E. Sulston, whose "seminal discoveries concerning the genetic regulation of organ development and programmed cell death" were "important for medical research and have shed new light on the pathogenesis of many diseases".
Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for "the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence". He has been selected to receive the 2015 Othmer Gold Medal.
Robert G. Roeder is an American biochemist. He is known as a pioneer scientist in eukaryotic transcription. He discovered three distinct nuclear RNA polymerases in 1969 and characterized many proteins involved in the regulation of transcription, including basic transcription factors and the first mammalian gene-specific activator over five decades of research. He is the recipient of the Gairdner Foundation International Award in 2000, the Albert Lasker Award for Basic Medical Research in 2003, and the Kyoto Prize in 2021. He currently serves as Arnold and Mabel Beckman Professor and Head of the Laboratory of Biochemical and Molecular Biology at The Rockefeller University.
Philip Arden Beachy is Ernest and Amelia Gallo Professor at Stanford University School of Medicine. Beachy isolated the Hedgehog gene in flies, discovered how it is processed and released from cells, and identified its signaling mechanism in target cells.
Cornelia Isabella "Cori" Bargmann is an American neurobiologist. She is known for her work on the genetic and neural circuit mechanisms of behavior using C. elegans, particularly the mechanisms of olfaction in the worm. She has been elected to the National Academy of Sciences and had been a Howard Hughes Medical Institute investigator at UCSF and then Rockefeller University from 1995 to 2016. She was the Head of Science at the Chan Zuckerberg Initiative from 2016 to 2022. In 2012 she was awarded the $1 million Kavli Prize, and in 2013 the $3 million Breakthrough Prize in Life Sciences.
Chiaho Shih is a Distinguished Research Fellow in the Division of Infectious Disease & Immunology, Institute of Biomedical Sciences, Academia Sinica in Taiwan. His research is in the area of Molecular virology, Viral hepatitis and Hepatoma, and Cancer.
Stuart A. Aaronson is an American author and cancer biologist. He has authored more than 500 publications and holds over 50 patents, and was the Jane B. and Jack R. Aron Professor of Neoplastic Diseases and Chairman of Oncological Sciences at The Mount Sinai Hospital in New York City until March 2013, when he assumed the title of Founding Chair Emeritus of the Department of Oncological Sciences. The current Chairman of Oncological Sciences is Ramon E. Parsons.
The hallmarks of cancer were originally six biological capabilities acquired during the multistep development of human tumors and have since been increased to eight capabilities and two enabling capabilities. The idea was coined by Douglas Hanahan and Robert Weinberg in their paper "The Hallmarks of Cancer" published January 2000 in Cell.
Douglas Hanahan is an American biologist, professor and director emeritus of the Swiss Institute for Experimental Cancer Research at EPFL in Lausanne, Switzerland. He is currently member of the Lausanne branch of the Ludwig Institute.
Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
David M. Sabatini is an American scientist and a former professor of biology at the Massachusetts Institute of Technology. From 2002 to 2021, he was a member of the Whitehead Institute for Biomedical Research. He was also an investigator of the Howard Hughes Medical Institute from 2008 to 2021 and was elected to the National Academy of Sciences in 2016. He is known for his contributions in the areas of cell signaling and cancer metabolism, most notably the co-discovery of mTOR.
Clifford James Tabin is chairman of the Department of Genetics at Harvard Medical School.
Ed Harlow is an American molecular biologist.
Breast cancer metastatic mouse models are experimental approaches in which mice are genetically manipulated to develop a mammary tumor leading to distant focal lesions of mammary epithelium created by metastasis. Mammary cancers in mice can be caused by genetic mutations that have been identified in human cancer. This means models can be generated based upon molecular lesions consistent with the human disease.
Scott William Lowe is Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is recognized for his research on the tumor suppressor gene, p53, which is mutated in nearly half of cancers.
Bradley E. Bernstein is a biologist and Professor of Cell Biology at Harvard Medical School. He is Chair of the Department of Cancer Biology at the Dana–Farber Cancer Institute and the Director of the Broad Institute's Gene Regulation Observatory. He is known for contributions to the fields of epigenetics and cancer biology.
Sendurai A. Mani is an Indian-American oncologist and a Molecular Biologist. He is a fellow of the American Association for the Advancement of Sciences, and Dean's Chair for Translational Oncology at Brown University Warren Alpert Medical School. He is also the associate director for Translational Oncology at the Legorreta Cancer Center at Alpert Medical School, Brown University. Previously, he was a co-director of Metastasis Research Center and co-director, the Center for Stem Cell & Developmental Biology, and a professor of Translational Molecular Pathology at MD Anderson Cancer Center.